John R. Chiminski

Companies

• QuidelBoard member Dec 10, 2024 to now¹
• Bruker Cellular Analysis, Inc.Board member May 18, 2021 to Oct 3, 2023²
• Catalent Pharma SolutionsChair Sep 18, 2017 to Aug 26, 2022³
• Catalent Pharma SolutionsChief executive officer Aug 1, 2017 to Oct 5, 2021⁴
• Catalent Pharma SolutionsPresident Aug 1, 2017 to Oct 3, 2018⁴
• Catalent Pharma SolutionsBoard member Jul 31, 2014 to Aug 28, 2017⁵
• Catalent Pharma SolutionsOfficer Jul 31, 2014 to Jul 26, 2017⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Quidel QDEL9,352 shares⁶$119.1K at $12.74May 29, 2026
• Catalent Pharma Solutions CTLT229,888 shares⁷Aug 25, 2022
• BCBruker Cellular Analysis, Inc.0 shares⁸Oct 2, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• May 29, 2026Granted 6,829 shares of Quidel⁶
• May 22, 2025Granted 2,523 shares of Quidel⁹
• Oct 2, 2023Returned to company 41,240 shares of Bruker Cellular Analysis, Inc.⁸
• Oct 2, 2023Returned to company 71,225 shares of Bruker Cellular Analysis, Inc.⁸
• May 25, 2023Granted 70,000 shares of Bruker Cellular Analysis, Inc.¹⁰
• Aug 25, 2022Sold 38,934 shares at $103.04 of Catalent Pharma Solutions⁷
• Aug 24, 2022Granted 99,275 shares of Catalent Pharma Solutions⁷
• Jul 26, 2022Granted 37,165 shares of Catalent Pharma Solutions¹¹
• Jul 26, 2022Sold 9,691 shares at $106.90 of Catalent Pharma Solutions¹¹
• May 26, 2022Granted 19,565 shares of Bruker Cellular Analysis, Inc.¹²
• Mar 11, 2022Bought 18,000 shares at $5.18 of Bruker Cellular Analysis, Inc.¹³
• Oct 1, 2021Sold 4,888 shares at $132.86 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Sold 64,031 shares at $132.18 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Sold 26,662 shares at $131.21 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Sold 21,245 shares at $130.39 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Sold 12,700 shares at $129.22 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Sold 18,510 shares at $128.10 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Sold 4,601 shares at $127.34 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Exercised options 34,635 shares at $43.88 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Exercised options 15,264 shares at $34.91 of Catalent Pharma Solutions¹⁴
• Oct 1, 2021Exercised options 25,939 shares at $36.02 of Catalent Pharma Solutions¹⁴